| Extrapulmonary Neuroendocrine Carcinoma studied in …STUDIED_INderived200 of 315show all (up to 200) |
|---|
| → studied in | NCT01824875Phase 2 · completed Temozolomide With or Without Capecitabine in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors · condition mapped ALIAS · 315 trials mapped (128 active) | — | — | Pancreatic Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03866382Phase 2 · recruiting Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors · condition mapped ONTOLOGY_EXACT · 315 trials mapped (128 active) | — | — | Bladder Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06479811Phase 1 · recruiting [212Pb]VMT-Alpha-NET in Metastatic or Inoperable Somatostatin-Receptor Positive Gastrointestinal Neuroendocrine Tumors, Pheochromocytoma/Paragangliomas, Small Cell Lung, Renal Cell, and Head and Neck Cancers · condition mapped ONTOLOGY_EXACT · 315 trials mapped (128 active) | — | — | Sinonasal Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07472322Phase 1/Phase 2 · not yet recruiting ASTX727 & Retifanlimab-dlwr for Advanced Merkel Cell After Progression on Anti-PD-(L)1 · condition mapped ONTOLOGY_EXACT · 315 trials mapped (128 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07509034Phase 1 · recruiting Autologous B7-H3 Chimeric Antigen Receptor T Cells in Previously Treated Extensive-Stage Small Cell Lung Cancer With Recurrent or Refractory Disease · condition mapped ONTOLOGY_EXACT · 315 trials mapped (128 active) | — | — | Extrapulmonary Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04216732recruiting Natural History of Medullary Thyroid Cancer to Inform Advanced Disease Management · condition mapped CURATED_BROADER · 315 trials mapped (128 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05583708Phase 2 · recruiting Phase II Study of Peptide Receptor Radionuclide Therapy in Combination With Immunotherapy for Patients With Merkel Cell Cancer · condition mapped ONTOLOGY_EXACT · 315 trials mapped (128 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07142005recruiting Cultural Adaptation of an Educational Tool in Medullary Thyroid Cancer · condition mapped ALIAS · 315 trials mapped (128 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02293954NA · active not recruiting Copper Cu 64 Anti-CEA Monoclonal Antibody M5A PET in Diagnosing Patients With CEA Positive Cancer · condition mapped ONTOLOGY_EXACT · 315 trials mapped (128 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06047379Phase 1/Phase 2 · recruiting Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis · condition mapped ONTOLOGY_EXACT · 315 trials mapped (128 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01660984active not recruiting Natural History Study of Children and Adults With Medullary Thyroid Cancer · condition mapped ALIAS · 315 trials mapped (128 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02471352recruiting Studies of Dermatologic Diseases Biospecimen Acquisition Protocol · condition mapped ALIAS · 315 trials mapped (128 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04522570NA · completed Thermal Ablation of Cervical Metastases From Thyroid Carcinoma · condition mapped ALIAS · 315 trials mapped (128 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06814496Phase 1/Phase 2 · recruiting Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors · condition mapped ALIAS · 315 trials mapped (128 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07006727Phase 1 · recruiting Phase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors · condition mapped ONTOLOGY_EXACT · 315 trials mapped (128 active) | — | — | Cervical Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07278479Phase 1/Phase 2 · recruiting Study of [212Pb]Pb-DOTAM-MAM279 ([212Pb]Pb-MP0712) in Patients With Small Cell Lung Cancer and Other DLL3 Expressing Solid Tumors · condition mapped ONTOLOGY_EXACT · 315 trials mapped (128 active) | — | — | Extrapulmonary Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06021626Phase 1 · recruiting A Study of CRD3874-SI in People With Solid Tumors · condition mapped ONTOLOGY_EXACT · 315 trials mapped (128 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07576725Phase 2 · not yet recruiting Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO Trial · condition mapped CURATED_BROADER · 315 trials mapped (128 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04467021NA · active not recruiting Cancer and Blood Pressure Management, CARISMA Study · condition mapped CURATED_BROADER · 315 trials mapped (128 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07080242Phase 1 · recruiting Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors · condition mapped CURATED_BROADER · 315 trials mapped (128 active) | — | — | Extrapulmonary Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05358938early Phase 1 · active not recruiting Exercise to Boost Response to Checkpoint Blockade Immunotherapy · condition mapped ONTOLOGY_EXACT · 315 trials mapped (128 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03074513Phase 2 · active not recruiting Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors · condition mapped CURATED_BROADER · 315 trials mapped (128 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04723095recruiting Establishing a Tumor Registry for Patients With Neuroendocrine Carcinoma of the Cervix · condition mapped ONTOLOGY_EXACT · 315 trials mapped (128 active) | — | — | Cervical Large Cell Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02496208Phase 1 · active not recruiting Cabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary Tumors · condition mapped ONTOLOGY_EXACT · 315 trials mapped (128 active) | — | — | Bladder Small Cell Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07812779not yet recruiting Thyroid Health Outcomes Registry for Surgery · condition mapped ALIAS · 315 trials mapped (128 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04592237Phase 2 · active not recruiting Cabazitaxel, Carboplatin, and Cetrelimab Followed by Niraparib With or Without Cetrelimab for the Treatment of Aggressive Variant Metastatic Prostate Cancer · condition mapped CURATED_BROADER · 315 trials mapped (128 active) | — | — | Prostate Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02479698Phase 2 · recruiting Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC Virus · condition mapped ONTOLOGY_EXACT · 315 trials mapped (128 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04047251Phase 1 · active not recruiting A Study of FF-10850 Topotecan Liposome Injection in Advanced Solid Tumors Including Merkel Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 315 trials mapped (128 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05247905Phase 2 · active not recruiting Comparing Capecitabine and Temozolomide in Combination to Lutetium Lu 177 Dotatate in Patients With Advanced Pancreatic Neuroendocrine Tumors, the ComPareNET Trial · condition mapped CURATED_BROADER · 315 trials mapped (128 active) | — | — | Pancreatic Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05864144Phase 1/Phase 2 · completed A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 315 trials mapped (128 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07720193Phase 3 · not yet recruiting A Trial of LBL-024 Combined With Platinum-based Chemotherapy for the Treatment of Advanced EP-NEC · condition mapped CURATED_BROADER · 315 trials mapped (128 active) | — | — | Extrapulmonary Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05896839Phase 1/Phase 2 · recruiting Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer · condition mapped CURATED_BROADER · 315 trials mapped (128 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02867592Phase 2 · active not recruiting Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors · condition mapped CURATED_BROADER · 315 trials mapped (128 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03304639Phase 2 · completed Testing the Addition of Radiation Therapy to Immunotherapy for Merkel Cell Carcinoma · condition mapped CURATED_BROADER · 315 trials mapped (128 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04670445NA · completed Improving Patient and Caregiver Understanding of Risks and Benefits of Immunotherapy for Advanced Cancer · condition mapped CURATED_BROADER · 315 trials mapped (128 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07488923Phase 1 · recruiting A First-in-human (FIH), Phase 1 Study of ML261, an Autologous Potency Enhanced Anti-DLL3 CAR T Cell Therapy, in Participants With R/R SCLC or Select NECs (SPECTRAL-1) · condition mapped ONTOLOGY_EXACT · 315 trials mapped (128 active) | — | — | Extrapulmonary Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05269381Phase 1/Phase 2 · recruiting Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors · condition mapped CURATED_BROADER · 315 trials mapped (128 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07115043Phase 1/Phase 2 · recruiting A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors · condition mapped ONTOLOGY_EXACT · 315 trials mapped (128 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02978625Phase 2 · active not recruiting Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers · condition mapped ONTOLOGY_EXACT · 315 trials mapped (128 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05859074Phase 1 · recruiting A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer · condition mapped ONTOLOGY_EXACT · 315 trials mapped (128 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04280081Phase 2 · active not recruiting A Study of Selpercatinib (LY3527723) in Participants With Advanced Solid Tumors Including RET Fusion-positive Solid Tumors, Medullary Thyroid Cancer and Other Tumors With RET Activation · condition mapped ALIAS · 315 trials mapped (128 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06056895Phase 2 · active not recruiting Triple Immune Checkpoint Inhibition for Advanced or Metastatic PD-(L)1 Refractory Merkel Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 315 trials mapped (128 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07713901enrolling by invitation Database Linkage Study to Evaluate the Risk of Medullary Thyroid Carcinoma · condition mapped ALIAS · 315 trials mapped (128 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03816332Phase 1 · active not recruiting Tacrolimus, Nivolumab, and Ipilimumab in Treating Kidney Transplant Recipients With Selected Unresectable or Metastatic Cancers · condition mapped CURATED_BROADER · 315 trials mapped (128 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03896503Phase 2 · active not recruiting Randomized Trial of Topotecan With M6620, an ATR Kinase Inhibitor, in Small Cell Lung Cancers and Small Cell Cancers Outside of the Lungs · condition mapped ONTOLOGY_EXACT · 315 trials mapped (128 active) | — | — | Extrapulmonary Small Cell Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05058651Phase 2/Phase 3 · suspended Evaluating the Addition of the Immunotherapy Drug Atezolizumab to Standard Chemotherapy Treatment for Advanced or Metastatic Neuroendocrine Carcinomas That Originate Outside the Lung · condition mapped CURATED_BROADER · 315 trials mapped (128 active) | — | — | Extrapulmonary Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05947500Phase 2 · active not recruiting Testing the Combination of Two Anticancer Drugs M1774 (Tuvusertib) and Avelumab to Evaluate Their Safety and Effectiveness in Treating Merkel Cell Skin Cancer, MATRiX Trial · condition mapped CURATED_BROADER · 315 trials mapped (128 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07259304active not recruiting Social Health, Activity Behaviors, and Quality of Life Among Young Adult Cancer Survivors · condition mapped CURATED_BROADER · 315 trials mapped (128 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07738159Phase 2 · not yet recruiting Iparomlimab and Tuvonralimab (QL1706) Plus Lenvatinib and Chemotherapy for Extrapulmonary Neuroendocrine Carcinoma · condition mapped ONTOLOGY_EXACT · 315 trials mapped (128 active) | — | — | Extrapulmonary Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07285044Phase 2 · recruiting The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas · condition mapped ONTOLOGY_EXACT · 315 trials mapped (128 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02595424Phase 2 · active not recruiting Cisplatin and Etoposide Versus Temozolomide and Capecitabine in Patients With Advanced Poorly Differentiated (G3) Non-Small Cell Gastrointestinal Neuroendocrine Carcinomas · condition mapped ONTOLOGY_EXACT · 315 trials mapped (128 active) | — | — | Gastric Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04471974Phase 2 · active not recruiting ZEN-3694, Enzalutamide, and Pembrolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer · condition mapped CURATED_BROADER · 315 trials mapped (128 active) | — | — | Prostate Small Cell Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04877613Phase 1 · active not recruiting GFRα4 CAR T Cells in MTC Patients · condition mapped CURATED_BROADER · 315 trials mapped (128 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05078047Phase 3 · active not recruiting Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients in Response After 6 Months of Standard IO · condition mapped ONTOLOGY_EXACT · 315 trials mapped (128 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03892993NA · recruiting Patient Decision Aid in Supporting Decision-Making About When to Start or Stop New Drugs, Join Clinical Trials, or Continue Active Surveillance in Patients With Medullary Thyroid Cancer and Their Caregivers · condition mapped ONTOLOGY_EXACT · 315 trials mapped (128 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05100095Phase 2 · recruiting Hypofractionated Radiation Therapy for Merkel Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 315 trials mapped (128 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01365169NA · recruiting Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients" · condition mapped ONTOLOGY_EXACT · 315 trials mapped (128 active) | — | — | Pancreatic Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05652686Phase 1/Phase 2 · recruiting A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study) · condition mapped ONTOLOGY_EXACT · 315 trials mapped (128 active) | — | — | Extrapulmonary Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05691465Phase 2 · recruiting Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells · condition mapped CURATED_BROADER · 315 trials mapped (128 active) | — | — | Prostate Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07302347Phase 1/Phase 2 · recruiting A Study of Pembrolizumab in Japanese Pediatric Participants With Solid Tumors or Lymphomas and Japanese Adult Participants With Merkel Cell Carcinoma (MK-3475-G21/KEYNOTE-G21) · condition mapped ONTOLOGY_EXACT · 315 trials mapped (128 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00113360Phase 2 · completed RAD001 Plus Octreotide Depot in Metastatic or Unresectable Low Grade Neuroendocrine Carcinoma · condition mapped ALIAS · 315 trials mapped (128 active) | — | — | Pancreatic Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07118176Phase 1 · active not recruiting Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers · condition mapped ONTOLOGY_EXACT · 315 trials mapped (128 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02856347NA · completed Prospective Study Evaluating the Medullary Thyroid Cancer Management's Care Using PET F-DOPA in Patients With a High Level of Postoperative Residual Thyrocalcitonin · condition mapped ALIAS · 315 trials mapped (128 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04975152Phase 1 · recruiting Neoadjuvant Cemiplimab in Newly Diagnosed or Recurrent Stage I-II Merkel Cell Carcinoma and Locoregionally Advanced Cutaneous Squamous Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 315 trials mapped (128 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07215988recruiting Studying Off Label Insurance Coverage for Patients With Cutaneous Cancers a "Filter" Observational Study · condition mapped CURATED_BROADER · 315 trials mapped (128 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07387198Phase 2 · recruiting Neoadjuvant Merkel Cell Carcinoma Therapy (Tx) With the PD-1 Inhibitor Cemiplimab · condition mapped CURATED_BROADER · 315 trials mapped (128 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07661420Phase 1 · not yet recruiting 211At-MABG in Adults With Advanced Neuroendocrine Cancers · condition mapped ALIAS · 315 trials mapped (128 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04616248Phase 1 · active not recruiting In Situ Immunomodulation With CDX-301, Radiation Therapy, CDX-1140 and Poly-ICLC in Patients w/ Unresectable and Metastatic Solid Tumors · condition mapped ONTOLOGY_EXACT · 315 trials mapped (128 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02834013Phase 2 · active not recruiting Nivolumab and Ipilimumab in Treating Patients With Rare Tumors · condition mapped ONTOLOGY_EXACT · 315 trials mapped (128 active) | — | — | Anal Canal Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03271372Phase 3 · active not recruiting Adjuvant Avelumab in Merkel Cell Cancer · condition mapped CURATED_BROADER · 315 trials mapped (128 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04705389NA · active not recruiting SerUM Markers in MERkel Cell Carcinoma Patients: a Longitudinal moniTorIng Study for optiMization of European Guidelines · condition mapped ONTOLOGY_EXACT · 315 trials mapped (128 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05076760Phase 1 · recruiting MEM-288 Oncolytic Virus Alone and in Combination With Standard of Care Therapy in Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 315 trials mapped (128 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04916002Phase 2 · terminated A Trial To Find Out If Vidutolimod Together With Cemiplimab Is Safe And If It Works In Adult Participants With Advanced Cancer Or Metastatic Cancer · condition mapped ONTOLOGY_EXACT · 315 trials mapped (128 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07621146not yet recruiting A Comparison of [68Ga]DOTATATE and [18F]AmBF3TATE for the Staging and Assessment of Neuroendocrine Malignancies · condition mapped ALIAS · 315 trials mapped (128 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03935893Phase 2 · active not recruiting Adoptive Transfer of Tumor Infiltrating Lymphocytes for Advanced Solid Cancers · condition mapped ONTOLOGY_EXACT · 315 trials mapped (128 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04514484Phase 1 · active not recruiting Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV · condition mapped CURATED_BROADER · 315 trials mapped (128 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07612293NA · not yet recruiting STAGE-MTC Trial Thyroid Lobectomy With Ipsilateral Central Neck Dissection · condition mapped ONTOLOGY_EXACT · 315 trials mapped (128 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03210935recruiting French National Database of Rare Dermatological Cancers · condition mapped ONTOLOGY_EXACT · 315 trials mapped (128 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04759911Phase 2 · active not recruiting Selpercatinib Before Surgery for the Treatment of RET-Altered Thyroid Cancer · condition mapped ONTOLOGY_EXACT · 315 trials mapped (128 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05988918Phase 2 · active not recruiting Multicenter Trial of ESK981 in Patients With Select Solid Tumors · condition mapped ONTOLOGY_EXACT · 315 trials mapped (128 active) | — | — | Pancreatic Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03583528active not recruiting DOTATOC PET/CT for Imaging NET Patients · condition mapped ONTOLOGY_EXACT · 315 trials mapped (128 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04010357Phase 2 · completed Targeted Therapy With CDK4/6 Inhibitors in Chemo-Refractory, Rb Wild-Type Extensive SCLC · condition mapped ALIAS · 315 trials mapped (128 active) | — | — | Extrapulmonary Small Cell Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02088645Phase 1 · active not recruiting 177Lu-PP-F11N for Receptor Targeted Therapy and Imaging of Metastatic Thyroid Cancer. · condition mapped ALIAS · 315 trials mapped (128 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04902040Phase 1/Phase 2 · terminated Plinabulin in Combination With Radiation/Immunotherapy in Patients With Select Advanced Cancers After Progression on PD-1 or PD-L1 Targeted Antibodies · condition mapped CURATED_BROADER · 315 trials mapped (128 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07328490Phase 1/Phase 2 · withdrawn Bispecific T-Cell Engager Tarlatamab and TROP2 Targeted Antibody Drug Conjugate Sacituzumab Govitecan in Previously Treated Extensive-Stage Small Cell Lung Cancer and Extrapulmonary Neuroendocrine Cancer · condition mapped ONTOLOGY_EXACT · 315 trials mapped (128 active) | — | — | Extrapulmonary Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04349436Phase 1/Phase 2 · active not recruiting Study to Investigate the Efficacy and Safety of RP1 in Adult Patients With Organ Transplants and Advanced Skin Malignancies · condition mapped ONTOLOGY_EXACT · 315 trials mapped (128 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05969860Phase 2 · recruiting At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer · condition mapped CURATED_BROADER · 315 trials mapped (128 active) | — | — | Prostate Small Cell Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01298323Phase 3 · completed Study to Determine if Contacting Patients With MTC More Frequently Results in Earlier Detection and Treatment of Signs and Symptoms of AEs and Thus a Decrease in the Percentage of Time Patients Experience AEs During First 12 Months on Vandetanib Treatment · condition mapped ALIAS · 315 trials mapped (128 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03157128Phase 1/Phase 2 · active not recruiting A Study of Selpercatinib (LOXO-292) in Participants With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer (LIBRETTO-001) · condition mapped ALIAS · 315 trials mapped (128 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06753136NA · recruiting Electrochemotherapy (ECT) in Patients With Primary Visceral Tumors and/or Secondary Visceral Localizations, of Any Histotype · condition mapped ONTOLOGY_EXACT · 315 trials mapped (128 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04291885Phase 2 · active not recruiting Immunotherapy Adjuvant Trial in Patients With Stage I-III Merkel Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 315 trials mapped (128 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06141369NA · recruiting Treatment of Advanced Endocrine Tumor With Iindividualized mRNA Neoantigen Vaccine (mRNA-0523-L001) · condition mapped ALIAS · 315 trials mapped (128 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04869137Phase 2 · active not recruiting Neoadjuvant Lenvatinib Plus Pembrolizumab in Merkel Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 315 trials mapped (128 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07518602Phase 2 · recruiting Efficacy and Safety of Chidamide+Sintilimab+Bev as Second-Line Therapy in Advanced Extrapulmonary Neuroendocrine Carcinoma · condition mapped ONTOLOGY_EXACT · 315 trials mapped (128 active) | — | — | Extrapulmonary Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04792073Phase 2 · active not recruiting Study of Avelumab and/or Radiation Therapy in People With Advanced Merkel Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 315 trials mapped (128 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04709276Phase 2 · active not recruiting A Study of Chemoimmunotherapy for the Treatment of Men With Neuroendocrine or Aggressive Variant Metastatic Prostate Cancer · condition mapped CURATED_BROADER · 315 trials mapped (128 active) | — | — | Prostate Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07510594Phase 2 · not yet recruiting A Phase II Study of Benmelstobart + Anlotinib + Chemotherapy as First-Line Treatment for LCNEC and EP-NEC · condition mapped ONTOLOGY_EXACT · 315 trials mapped (128 active) | — | — | Extrapulmonary Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07501650Phase 1 · recruiting Pembrolizumab Plus Ultrasound-Induced Microbubble Cavitation in Head and Neck Cancer · condition mapped ALIAS · 315 trials mapped (128 active) | — | — | Head and Neck Small Cell Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04234113Phase 1 · terminated Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid Tumors · condition mapped ONTOLOGY_EXACT · 315 trials mapped (128 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04261855Phase 1/Phase 2 · active not recruiting Targeted Therapy and Avelumab in Merkel Cell Carcinoma · condition mapped CURATED_BROADER · 315 trials mapped (128 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07276360Phase 2 · recruiting Hypofractionated Radiotherapy for the Treatment of Locally Advanced Cervical Cancer in Uganda · condition mapped ALIAS · 315 trials mapped (128 active) | — | — | Cervical Small Cell Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06008977NA · active not recruiting Exercise to Boost Response to Checkpoint Blockade Immunotherapy · condition mapped ONTOLOGY_EXACT · 315 trials mapped (128 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04211337Phase 3 · active not recruiting A Study of Selpercatinib (LY3527723) in Participants With RET-Mutant Medullary Thyroid Cancer · condition mapped ALIAS · 315 trials mapped (128 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03071406Phase 2 · active not recruiting Randomized Study of Nivolumab+Ipilimumab+/- SBRT for Metastatic Merkel Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 315 trials mapped (128 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06223659Phase 2 · recruiting EMLA Topical Cream for Treatment of Pain in Patients Receiving Intra-Dermal Technetium 99 Injections for Lymphoscintigraphy for Skin Cancers · condition mapped ONTOLOGY_EXACT · 315 trials mapped (128 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00830557recruiting Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders · condition mapped ONTOLOGY_EXACT · 315 trials mapped (128 active) | — | — | Pancreatic Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05496036Phase 2 · recruiting Neoadjuvant PD-1 Blockade in Resectable Merkel Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 315 trials mapped (128 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06151236Phase 2 · recruiting Neoadjuvant Nivolumab and Relatlimab in Merkel Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 315 trials mapped (128 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07288073Phase 2 · recruiting TIL Therapy in cSCC and MCC · condition mapped ONTOLOGY_EXACT · 315 trials mapped (128 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04754425Phase 2 · terminated Erdafitinib for the Treatment of Patients With Castration-Resistant Prostate Cancer · condition mapped CURATED_BROADER · 315 trials mapped (128 active) | — | — | Prostate Small Cell Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06939036Phase 1/Phase 2 · terminated Study of 225Ac-SS0110 in Subjects With ES-SCLC or MCC (SANTANA-225 ) · condition mapped ONTOLOGY_EXACT · 315 trials mapped (128 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07383246Phase 3 · recruiting CTR-FAPI-guided Precision Surgery for Newly Diagnosed MTC · condition mapped ALIAS · 315 trials mapped (128 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03228667Phase 2 · active not recruiting QUILT-3.055: A Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment With Immune Checkpoint Inhibitors · condition mapped ONTOLOGY_EXACT · 315 trials mapped (128 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05594290Phase 2 · active not recruiting Chemo-immunotherapy in Patients With Resectable Merkel Cell Carcinoma Prior to Surgery · condition mapped ONTOLOGY_EXACT · 315 trials mapped (128 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04260802Phase 1/Phase 2 · terminated A Study to Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic Cancers · condition mapped ONTOLOGY_EXACT · 315 trials mapped (128 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03899792Phase 1/Phase 2 · active not recruiting A Study of Oral LOXO-292 (Selpercatinib) in Pediatric Participants With Advanced Solid or Primary Central Nervous System (CNS) Tumors · condition mapped ALIAS · 315 trials mapped (128 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04157985Phase 3 · completed Evaluating Length of Treatment With PD-1/PD-L1 Inhibitor in Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 315 trials mapped (128 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05120271Phase 1/Phase 2 · active not recruiting BOXR1030 T Cells in Subjects With Advanced GPC3-Positive Solid Tumors · condition mapped ONTOLOGY_EXACT · 315 trials mapped (128 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07252661Phase 1 · not yet recruiting Study of ACC-1898 in Adult Participants With Advanced Solid Tumors · condition mapped ALIAS · 315 trials mapped (128 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04725331Phase 1/Phase 2 · terminated A Clinical Trial Assessing BT-001 Alone and in Combination With Pembrolizumab in Metastatic or Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 315 trials mapped (128 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03582475Phase 1 · active not recruiting Pembrolizumab With Combination Chemotherapy in Treating Participants With Locally Advanced or Metastatic Small Cell/Neuroendocrine Cancers of Urothelium or Prostate · condition mapped ONTOLOGY_EXACT · 315 trials mapped (128 active) | — | — | Bladder Small Cell Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06062745Phase 1 · recruiting Pilot Study for Detection of PSMA-Low CRPC-NE Tumors With Fluciclovine PET/CT · condition mapped CURATED_BROADER · 315 trials mapped (128 active) | — | — | Prostate Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03901573Phase 1/Phase 2 · terminated High-Risk Skin Cancers With Atezolizumab Plus NT-I7 · condition mapped ONTOLOGY_EXACT · 315 trials mapped (128 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04272034Phase 1 · terminated Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099318 in Participants With Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 315 trials mapped (128 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06940440Phase 1 · recruiting IFx-Hu2.0 As An Adjunctive Therapy To Pembrolizumab In Advanced Or Metastatic Merkel Cell Carcinoma (MCC) · condition mapped ONTOLOGY_EXACT · 315 trials mapped (128 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06536257recruiting Personalised Immunotherapy Platform · condition mapped ONTOLOGY_EXACT · 315 trials mapped (128 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01896479Phase 4 · active not recruiting A Study of Two Different Doses of Cabozantinib (XL184) in Progressive, Metastatic Medullary Thyroid Cancer · condition mapped ALIAS · 315 trials mapped (128 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07138716NA · recruiting Research on the Application of 68Ga-DOTA-CCK-FS PET/CT in MTC · condition mapped ALIAS · 315 trials mapped (128 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03599713Phase 2 · completed A Study of INCMGA00012 in Metastatic Merkel Cell Carcinoma (POD1UM-201) · condition mapped CURATED_BROADER · 315 trials mapped (128 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06541652recruiting A French Multicenter Observational Retrospective Study of Rare Primary Liver Cancers · condition mapped ALIAS · 315 trials mapped (128 active) | — | — | Liver Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05173246Phase 2 · recruiting JS001 Combined With TP as First-line Treatment for Unresectable or Advanced Small Cell Esophageal Carcinoma · condition mapped ALIAS · 315 trials mapped (128 active) | — | — | Esophageal Small Cell Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04116320Phase 1 · terminated Focused Ultrasound Ablation and PD-1 Antibody Blockade in Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 315 trials mapped (128 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04242199Phase 1 · completed Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099280 in Participants With Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 315 trials mapped (128 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05086692Phase 1/Phase 2 · recruiting A Beta-only IL-2 ImmunoTherapY Study · condition mapped ONTOLOGY_EXACT · 315 trials mapped (128 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07048964not yet recruiting A Prospective Cohort Study of Pralsetinib or Anlotinib in the Treatment of Locally Advanced and/or Metastatic Medullary Thyroid Carcinoma With RET Gene Mutations · condition mapped ALIAS · 315 trials mapped (128 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05534594NA · completed Evaluation of the 18F-PSMA Positron Emission Tomography (PET)/CT in Patients With Medullary Thyroid Cancer · condition mapped ALIAS · 315 trials mapped (128 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03037385Phase 1/Phase 2 · completed Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors · condition mapped ALIAS · 315 trials mapped (128 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03783078Phase 3 · completed Pembrolizumab (MK-3475) as First-line Therapy for Advanced Merkel Cell Carcinoma (MK-3475-913) · condition mapped ONTOLOGY_EXACT · 315 trials mapped (128 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02230176Phase 2 · completed Antitumor Efficacy of Peptide Receptor Radionuclide Therapy With 177Lutetium -Octreotate Randomized vs Sunitinib in Unresectable Progressive Well-differentiated Neuroendocrine Pancreatic Tumor: First Randomized Phase II · condition mapped ONTOLOGY_EXACT · 315 trials mapped (128 active) | — | — | Pancreatic Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02196961Phase 2 · completed Adjuvant Therapy of Completely Resected Merkel Cell Carcinoma With Immune Checkpoint Blocking Antibodies vs Observation · condition mapped ONTOLOGY_EXACT · 315 trials mapped (128 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06094842Phase 1 · withdrawn Autologous T Cells Lentivirally Transduced to Express L1CAM-Specific Chimeric Antigen Receptors in Treating Patients With Locally Advanced and Unresectable or Metastatic Small Cell Neuroendocrine Prostate Cancer · condition mapped ONTOLOGY_EXACT · 315 trials mapped (128 active) | — | — | Prostate Small Cell Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00381641Phase 2 · completed Sunitinib Malate in Treating Patients With Thyroid Cancer That Did Not Respond to Iodine I 131 and Cannot Be Removed by Surgery · condition mapped CURATED_BROADER · 315 trials mapped (128 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06852144enrolling by invitation PET-TC in Thyroid Evaluation · condition mapped ALIAS · 315 trials mapped (128 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03167164Phase 1/Phase 2 · withdrawn QUILT-3.045: NANT Merkel Cell Carcinoma (MCC) Vaccine: Combination Immunotherapy in Subjects With MCC Who Have Progressed on or After PD-L1 Therapy · condition mapped ONTOLOGY_EXACT · 315 trials mapped (128 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03212404Phase 1 · active not recruiting Phase 1 Study of CK-301 (Cosibelimab) as a Single Agent in Subjects With Advanced Cancers · condition mapped ONTOLOGY_EXACT · 315 trials mapped (128 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03736720Phase 2 · terminated Liposomal Irinotecan, Fluorouracil and Leucovorin in Treating Patients With Refractory Advanced High Grade Neuroendocrine Cancer of Gastrointestinal, Unknown, or Pancreatic Origin · condition mapped CURATED_BROADER · 315 trials mapped (128 active) | — | — | Digestive System Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02819843Phase 2 · completed A Study of T-VEC (Talimogene Laherparepvec) With or Without Radiotherapy for Melanoma, Merkel Cell Carcinoma, or Other Solid Tumors · condition mapped ONTOLOGY_EXACT · 315 trials mapped (128 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03906331approved for marketing Expanded Access for the Treatment of Cancers With Rearranged During Transfection (RET) Activation · condition mapped ALIAS · 315 trials mapped (128 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06292988completed Predictive Factors for Medullary Thyroid Cancer Aggressiveness · condition mapped ALIAS · 315 trials mapped (128 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01945762completed Observational Study to Evaluate Vandetanib in RET -/+ Patients With Metastatic Medullary Thyroid Cancer · condition mapped ALIAS · 315 trials mapped (128 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06663852completed ML Decision Model for G-NEC Adjuvant Therapy · condition mapped ONTOLOGY_EXACT · 315 trials mapped (128 active) | — | — | Gastric Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05797415recruiting Sentinel Lymph Node Biopsy in Ocular Surface and Adnexal Cancers · condition mapped ONTOLOGY_EXACT · 315 trials mapped (128 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04160065Phase 1 · completed Immunotherapy With IFx-Hu2.0 Vaccine for Advanced Non-melanoma Skin Cancers · condition mapped ONTOLOGY_EXACT · 315 trials mapped (128 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04970134active not recruiting Spanish Study for Molecular Characterization of Thyroid Carcinoma · condition mapped ALIAS · 315 trials mapped (128 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03370861terminated How Microbes and Metabolism May Predict Skin Cancer Immunotherapy Outcomes · condition mapped ONTOLOGY_EXACT · 315 trials mapped (128 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00655655Phase 1 · completed Everolimus and Vatalanib in Treating Patients With Advanced Solid Tumors · condition mapped CURATED_BROADER · 315 trials mapped (128 active) | — | — | Pancreatic Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04853602available IFx-Hu2.0 Expanded Access Program · condition mapped ONTOLOGY_EXACT · 315 trials mapped (128 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03853317Phase 2 · terminated QUILT-3.063: A Study of N-803, haNK and Avelumab in Patients With Merkel Cell Carcinoma That Has Progressed After Checkpoint Therapy · condition mapped ONTOLOGY_EXACT · 315 trials mapped (128 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06523582recruiting Genetic Bases of Neuroendocrine Neoplasms in Mexican Patients · condition mapped ALIAS · 315 trials mapped (128 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06520319Phase 1 · unknown Head-to-head Study of 68Ga-MGS5 Versus 68Ga-DOTATATE PET/CT in Patients With Medullary Thyroid Carcinoma · condition mapped ALIAS · 315 trials mapped (128 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05013099Phase 2 · unknown Study of Zirconium Zr 89 Crefmirlimab Berdoxam PET/CT in Subjects With Advanced or Metastatic Malignancies · condition mapped ONTOLOGY_EXACT · 315 trials mapped (128 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01856920Phase 2 · completed QUILT-3.006 for Recurrent Medullary Thyroid Cancer · condition mapped ALIAS · 315 trials mapped (128 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06478264Phase 2 · not yet recruiting A Study of Adebrelimab Combined With Chemoradiotherapy in the Treatment of Esophageal Small Cell Carcinoma · condition mapped ALIAS · 315 trials mapped (128 active) | — | — | Esophageal Small Cell Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06464068Phase 2 · recruiting AGNOSTIC THERAPY IN A PHASE II SINGLE-ARM STUDY IN FIRST-LINE TREATMENT OF DURVALUMAB IN ASSOCIATION WITH CARBOPLATIN OR CISPLATIN AND ETOPOSIDE IN PATIENTS AFFECTED BY EXTENSIVE STAGE - EXTRAPULMONARY SMALL CELL CARCINOMA · condition mapped ALIAS · 315 trials mapped (128 active) | — | — | Extrapulmonary Small Cell Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04161391Phase 1/Phase 2 · terminated Study of TPX-0046, A RET/SRC Inhibitor in Adult Subjects With Advanced Solid Tumors Harboring RET Fusions or Mutations · condition mapped ALIAS · 315 trials mapped (128 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06448611not yet recruiting Identification and Characterization of Circulating Tumor Cells Before and After Treatment (Surgery and Radiotherapy) in a Cohort of Patients Treated for Resectable Stage I-III Merkel Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 315 trials mapped (128 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03629756Phase 1 · completed A Study to Evaluate the Safety and Tolerability of Immunotherapy Combinations in Participants With Advanced Malignancies · condition mapped ONTOLOGY_EXACT · 315 trials mapped (128 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02164461Phase 1 · completed Axalimogene Filolisbac (ADXS11-001) High Dose in Women With Human Papillomavirus (HPV) + Cervical Cancer · condition mapped ALIAS · 315 trials mapped (128 active) | — | — | Cervical Small Cell Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04393753Phase 2 · completed Domatinostat in Combination With Avelumab in Patients With Advanced Merkel Cell Carcinoma Progressing on Anti-PD-(L)1 · condition mapped ONTOLOGY_EXACT · 315 trials mapped (128 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05253144NA · completed Comparing Radical Surgery and Radical Radiotherapy as First Definitive Treatment for Primary MCC · condition mapped ONTOLOGY_EXACT · 315 trials mapped (128 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02465957Phase 2 · terminated QUILT-3.009: Patients With Stage III (IIIB) or Stage (IV) Merkel Cell Carcinoma (MCC) · condition mapped CURATED_BROADER · 315 trials mapped (128 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03798639Phase 1 · completed Nivolumab and Radiation Therapy or Ipilimumab as Adjuvant Therapy in Treating Patients With Merkel Cell Cancer · condition mapped ONTOLOGY_EXACT · 315 trials mapped (128 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02155647Phase 2 · completed Avelumab in Participants With Merkel Cell Carcinoma (JAVELIN Merkel 200) · condition mapped ONTOLOGY_EXACT · 315 trials mapped (128 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02592356NA · completed Effect of Cabozantinib S-Malate or Lenvatinib Mesylate on Weight and Body Composition in Patients With Metastatic Endocrine Cancer · condition mapped ONTOLOGY_EXACT · 315 trials mapped (128 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06277180NA · recruiting 68Ga-TCR-FAPI PET/CT Guided Precision Surgery for MTC · condition mapped ALIAS · 315 trials mapped (128 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00390325Phase 2 · completed Sorafenib Tosylate in Treating Patients With Metastatic, Locally Advanced, or Recurrent Medullary Thyroid Cancer · condition mapped ONTOLOGY_EXACT · 315 trials mapped (128 active) | — | — | Hereditary Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01525082Phase 2 · completed Capecitabine, Temozolomide, and Bevacizumab for Metastatic or Unresectable Pancreatic Neuroendocrine Tumors · condition mapped CURATED_BROADER · 315 trials mapped (128 active) | — | — | Pancreatic Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06243965completed Is Desmoplastic Stromal Reaction Useful to Modulate Lymph Node Dissection in Sporadic Medullary Thyroid Carcinoma? · condition mapped ALIAS · 315 trials mapped (128 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05675605Phase 1/Phase 2 · unknown A Study of TY-1091 in Patients With Advanced Solid Tumors · condition mapped ALIAS · 315 trials mapped (128 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04760288Phase 3 · withdrawn A Study of Pralsetinib Versus Standard of Care (SOC) for Treatment of RET-Mutated Medullary Thyroid Cancer (MTC). · condition mapped ALIAS · 315 trials mapped (128 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04187872Phase 1 · terminated LITT and Pembrolizumab in Recurrent Brain Metastasis · condition mapped ONTOLOGY_EXACT · 315 trials mapped (128 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01709435Phase 1 · completed Cabozantinib S-Malate in Treating Younger Patients With Recurrent or Refractory Solid Tumors · condition mapped ONTOLOGY_EXACT · 315 trials mapped (128 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06121271Phase 2 · not yet recruiting Trial of Lu-177 DOTATATE (Lutathera®) in Unlicensed Indications · condition mapped ALIAS · 315 trials mapped (128 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05422781Phase 1 · completed Study To Evaluate The Safety, Tolerability And Immunogenicity Of 4 mg Of ITI-3000 In Patients With Polyomavirus-Positive Merkel Cell Carcinoma (MCC) · condition mapped ONTOLOGY_EXACT · 315 trials mapped (128 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03649841Phase 2 · terminated Antiandrogen Therapy, Abiraterone Acetate, and Prednisone With or Without Neutron Radiation Therapy in Treating Patients With Prostate Cancer · condition mapped ONTOLOGY_EXACT · 315 trials mapped (128 active) | — | — | Prostate Small Cell Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06102746unknown Clinical Study of Surufatinib Plus Sintilimab Combined With Chemotherapy in the Treatment of Advanced Gastric Neuroendocrine Carcinoma · condition mapped ONTOLOGY_EXACT · 315 trials mapped (128 active) | — | — | Gastric Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02893930Phase 2 · completed Sapanisertib in Treating Patients With Metastatic or Refractory Pancreatic Neuroendocrine Tumor That Cannot Be Removed by Surgery · condition mapped CURATED_BROADER · 315 trials mapped (128 active) | — | — | Pancreatic Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06086288Phase 2 · not yet recruiting Study of PembrolizumAb combiNeD With Cisplatin or carbOplatin and Etoposide in Treatment naïve Advanced meRkel Cell cArcinoma (MCC) · condition mapped ONTOLOGY_EXACT · 315 trials mapped (128 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06079723not yet recruiting A Detailed Look At What Patients Experience In Medullary Thyroid Cancer Clinical Study · condition mapped ALIAS · 315 trials mapped (128 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05329792Phase 2 · unknown L19IL2/L19TNF in Skin Cancer Patients · condition mapped ONTOLOGY_EXACT · 315 trials mapped (128 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06067594completed Calcitonin in Needle Wash Using Electrochemiluminescence Method For Diagnosis Of Medullary Thyroid Carcinoma. · condition mapped ALIAS · 315 trials mapped (128 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06070740Phase 2 · recruiting First- Line Treatment With Durvalumab Plus XELOX Chemotherapy in Advanced Gastrointestinal Neuroendocrine Carcinoma · condition mapped ALIAS · 315 trials mapped (128 active) | — | — | Digestive System Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04106167terminated Long-term, Non-interventional, Observational Study Following Treatment With Fate Therapeutics FT500 Cellular Immunotherapy · condition mapped ONTOLOGY_EXACT · 315 trials mapped (128 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06039033not yet recruiting Exploring Merkel Cell Carcinoma Clinical Trial Engagement Patterns · condition mapped ONTOLOGY_EXACT · 315 trials mapped (128 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05830500Phase 4 · recruiting Study of Anlotinib in Patients With Advanced Medullary Thyroid Carcinoma · condition mapped ALIAS · 315 trials mapped (128 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02267603Phase 2 · completed Pembrolizumab in Treating Patients With Advanced Merkel Cell Cancer · condition mapped CURATED_BROADER · 315 trials mapped (128 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02031536Phase 2 · terminated Everolimus in Patients With Pancreatic Neuroendocrine Tumors Metastatic to the Liver Previously Treated With Surgery · condition mapped CURATED_BROADER · 315 trials mapped (128 active) | — | — | Pancreatic Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01511393enrolling by invitation An Active Surveillance Program for Cases of Medullary Thyroid Carcinoma (MTC) · condition mapped ALIAS · 315 trials mapped (128 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01440816Phase 2 · completed IL-12 Gene and in Vivo Electroporation-Mediated Plasmid DNA Vaccine Therapy in Patients With Merkel Cell Cancer · condition mapped ONTOLOGY_EXACT · 315 trials mapped (128 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02036476Phase 2 · terminated Cabozantinib in Recurrent/Metastatic Merkel Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 315 trials mapped (128 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |